DSPP Gene Deafness Autosomal Dominant Type 39 with Dentinogenesis Type 1 Genetic Test
At DNA Labs UAE, we offer the DSPP Gene Deafness Autosomal Dominant Type 39 with Dentinogenesis Type 1 Genetic Test at a cost of AED 4400.0.
Test Components:
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Ear Nose Throat Disorders
- Doctor: ENT Doctor
- Test Department: Genetics
Pre Test Information:
Before undergoing the SLC52A3 Gene Brown-Vialetto-Van Laere syndrome 1 NGS Genetic DNA Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected with SLC52A3 Gene Brown-Vialetto-Van Laere syndrome 1 NGS Genetic DNA Test gene SLC52A6.
Test Details:
DSPP gene deafness, autosomal dominant type 39, with dentinogenesis type 1 is a genetic disorder that affects both hearing and tooth development. It is caused by mutations in the DSPP gene. The DSPP gene provides instructions for producing a protein called dentin sialophosphoprotein, which is essential for the formation of dentin, a hard tissue that makes up the bulk of teeth. Mutations in the DSPP gene can disrupt the normal production or function of dentin sialophosphoprotein, leading to abnormal tooth development. In addition to tooth abnormalities, individuals with DSPP gene mutations may also experience hearing loss. The exact mechanism by which DSPP mutations cause deafness is not fully understood.
To diagnose DSPP gene deafness, autosomal dominant type 39, with dentinogenesis type 1, a genetic test called Next-Generation Sequencing (NGS) can be performed. NGS is a high-throughput method that allows for the simultaneous analysis of multiple genes, including the DSPP gene, to identify any disease-causing mutations. The NGS genetic test involves obtaining a DNA sample, typically through a blood sample or saliva swab, from the individual being tested. The DNA is then sequenced using NGS technology, and the resulting data is analyzed to identify any mutations or variations in the DSPP gene.
A positive result from the NGS genetic test would indicate the presence of DSPP gene mutations associated with deafness and dentinogenesis type 1. This information can help in confirming a diagnosis, providing genetic counseling, and guiding treatment options for affected individuals and their families.
| Test Name | DSPP Gene Deafness autosomal dominant type 39 with dentinogenesis type 1 Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Ear Nose Throat Disorders |
| Doctor | ENT Doctor |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for SLC52A3 Gene Brown-Vialetto-Van Laere syndrome 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SLC52A3 Gene Brown-Vialetto-Van Laere syndrome 1 NGS Genetic DNA Test gene SLC52A6 |
| Test Details |
DSPP gene deafness, autosomal dominant type 39, with dentinogenesis type 1 is a genetic disorder that affects both hearing and tooth development. It is caused by mutations in the DSPP gene. The DSPP gene provides instructions for producing a protein called dentin sialophosphoprotein, which is essential for the formation of dentin, a hard tissue that makes up the bulk of teeth. Mutations in the DSPP gene can disrupt the normal production or function of dentin sialophosphoprotein, leading to abnormal tooth development. In addition to tooth abnormalities, individuals with DSPP gene mutations may also experience hearing loss. The exact mechanism by which DSPP mutations cause deafness is not fully understood. To diagnose DSPP gene deafness, autosomal dominant type 39, with dentinogenesis type 1, a genetic test called Next-Generation Sequencing (NGS) can be performed. NGS is a high-throughput method that allows for the simultaneous analysis of multiple genes, including the DSPP gene, to identify any disease-causing mutations. The NGS genetic test involves obtaining a DNA sample, typically through a blood sample or saliva swab, from the individual being tested. The DNA is then sequenced using NGS technology, and the resulting data is analyzed to identify any mutations or variations in the DSPP gene. A positive result from the NGS genetic test would indicate the presence of DSPP gene mutations associated with deafness and dentinogenesis type 1. This information can help in confirming a diagnosis, providing genetic counseling, and guiding treatment options for affected individuals and their families. |
